Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
RLS Therapeutics
AddedFeb 16, 2024
UpdatedJun 18, 2026
RLS Therapeutics

RLS Therapeutics

Pre-Seed

RLS Therapeutics develops novel small molecule treatments for various diseases.

HQ
Nashville, TN, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to innovate in the pharmaceutical landscape, RLS Therapeutics focuses on developing novel small molecule therapeutics to address a wide range of diseases. The company leverages its proprietary technology, RPRx (Recycling Polycarbonyl Redox Therapy), which targets health disorders linked to impaired mitochondrial function. By prioritizing the reduction of risk in drug development, RLS Therapeutics aims to bring effective treatments to market more efficiently.

Notable figures associated with RLS Therapeutics include leading scientists and industry experts who contribute to its pioneering research and development efforts. The company has garnered attention for its innovative approach and potential impact on treating mitochondrial-related disorders. Through its commitment to advancing medical science, RLS Therapeutics is poised to make significant contributions to the healthcare industry, improving patient outcomes and setting new standards in therapeutic development.

RLS Therapeutics - Similar Companies

Rediscovery Life Sciences logo

Rediscovery Life Sciences

rediscoveryls.com

RS BioTherapeutics logo

RS BioTherapeutics

Rubix LS logo

Rubix LS

rubixls.com

Relay Therapeutics logo

Relay Therapeutics

relaytx.com

Lysosomal Therapeutics logo

Lysosomal Therapeutics

lysosomaltx.com

Resilience Therapeutics logo

Resilience Therapeutics

Asha Therapeutics logo

Asha Therapeutics

Lucy Therapeutics logo

Lucy Therapeutics

Receptor Life Sciences logo

Receptor Life Sciences

receptorlife.com

Rjs Biologics logo

Rjs Biologics

Exalys Therapeutics logo

Exalys Therapeutics

Mitochon Pharmaceuticals logo

Mitochon Pharmaceuticals

mitochonpharma.com

Pretzel Therapeutics logo

Pretzel Therapeutics

pretzeltx.com

Remix Therapeutics logo

Remix Therapeutics

Retro Biosciences logo

Retro Biosciences

retro.bio

RLS Therapeutics - Quick Facts

Who are RLS Therapeutics' competitors?

Companies similar to RLS Therapeutics include Rediscovery Life Sciences, RS BioTherapeutics, Rubix LS and Relay Therapeutics.

When was RLS Therapeutics founded?

RLS Therapeutics was founded in 2016.

Where is RLS Therapeutics' headquarters located?

RLS Therapeutics' headquarters is located in Nashville, TN, US.

When was RLS Therapeutics' last funding round?

RLS Therapeutics' most recent funding round was for $635k (USD) in November 2019.

How much has RLS Therapeutics raised to-date?

As of Nov 1, 2019, RLS Therapeutics has raised a total of $1.4M (USD).

How many employees does RLS Therapeutics have?

RLS Therapeutics has 7 employees as of Feb 4, 2024.

RLS Therapeutics - Classification

Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drugs
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified